The Management of Coronary Artery Disease in Ethiopia: Emphasis on Revascularization

Bekele Alemayehu Shashu1

  • 1MD, Internist, Interventional Cardiologist, Associate Professor of Medicine, Addis Ababa University.

Insights

Coronary artery disease, a leading cause of death, involves plaque buildup in arteries. Revascularization improves survival in specific chronic coronary syndrome cases, especially with severe blockages.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Diagnostic Imaging

Background:

  • Cardiovascular diseases are the leading global cause of mortality.
  • Coronary artery disease (CAD) accounts for over half of these deaths, stemming from atherosclerotic plaque in coronary arteries.
  • Plaque rupture is a primary cause of myocardial infarction and associated fatalities.

Purpose of the Study:

  • To review diagnostic approaches for obstructive coronary artery disease.
  • To outline treatment strategies for acute and chronic coronary syndromes.
  • To highlight the role of revascularization in specific CAD patient subgroups.

Main Methods:

  • Review of diagnostic performance of exercise electrocardiography versus imaging tests.
  • Identification of key diagnostic markers for acute coronary syndrome (ACS).
  • Analysis of revascularization benefits in chronic coronary syndrome (CCS) based on stenosis severity and location.

Main Results:

  • Exercise electrocardiography shows inferior diagnostic performance compared to imaging tests for obstructive CAD.
  • Electrocardiography and serum troponin levels are pivotal in diagnosing ACS.
  • Revascularization significantly reduces mortality in specific CCS scenarios, including left main stenosis and severe multi-vessel disease.

Conclusions:

  • Diagnostic imaging surpasses exercise ECG for obstructive CAD detection.
  • Prompt diagnosis of ACS relies on ECG and troponin.
  • Revascularization is a critical intervention for select patients with chronic coronary syndrome, improving survival rates.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
84
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
69
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
87
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
87
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
431
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
110